Fig. 3
From: Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles
In vivo tracking of HA-HPPS and MLT-HA-HPPS to target normal popliteal LN. a Fluorescence imaging of the target ability of HA-HPPS and MLT-HA-HPPS in normal popliteal LNs (PLN) at 1, 3, 6, 12, and 24 h after footpad injection. b Representative fluorescence imaging of the dissected organs and LNs after 24 h footpad injection. c Quantitative analysis of the MFI of DiR-BOA in the organs and PLNs (n = 3 per group). iPLN ipsilateral popliteal LN, cPLN contralateral popliteal LN